Arch Chemicals posted a surprise quarterly profit as higher pricing and the favorable impact of a recent acquisition offset lower volumes and unfavorable foreign exchange. Net income for the quarter was $3.2 million, or 13 cents a share, compared with $5.7 million, or 23 cents a share, in the same quarter last year. Sales fell 15 % to $293.7 million.
Compelling solutions through strategic partnerships
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
